Question 1

Does JPMorgan Chase own ORKA stock?

Accepted Answer

Yes. As of its Q2 2026 13F, JPMorgan Chase holds 655,027 shares of ORKA (Oruka Therapeutics), worth $60.7M.

Question 2

How many shares of ORKA does JPMorgan Chase own?

Accepted Answer

As of its Q2 2026 13F, JPMorgan Chase holds 655,027 shares of ORKA (Oruka Therapeutics).

Question 3

What is JPMorgan Chase's ORKA position worth?

Accepted Answer

As of its Q2 2026 13F, JPMorgan Chase's ORKA position is worth $60.7M.

Question 4

Is JPMorgan Chase buying or selling ORKA?

Accepted Answer

In Q2 2026, JPMorgan Chase increased its ORKA position from 22,620 to 655,027 shares.

Question 5

When did JPMorgan Chase first buy ORKA?

Accepted Answer

JPMorgan Chase first reported ORKA in its Q4 2024 13F and has listed it in 7 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	655,027	+2795.8%	$60.7M	0.0%	$95.17	48
2026-Q1	Increased	22,620	+10.8%	$1M	0.0%	$49.05	28
2025-Q4	Increased	20,417	+41.0%	$618,839	0.0%	$30.31	22
2025-Q3	Decreased	14,479	-6.1%	$278,431	0.0%	$19.23	0
2025-Q2	Increased	15,425	+567.8%	$172,914	0.0%	$11.21	25
2025-Q1	Decreased	2,310	-17.5%	$23,701	0.0%	$10.26	0
2024-Q4	New	2,800	-	$54,292	0.0%	$19.39	32

ORKA7 quarters

ORKA
7 quarters